Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treprostinil iontophoresis for digital ulcers in systemic sclerosis
NCT03120533Phase 2Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in systemic sclerosis (SSc) and digital ulcer (DU) comparing Treprostinil Arm with Placebo Arm (2 arms). Primary endpoint: Number of side-effects graduated according to NIH CTCAE 4.03 at day 9. Started Jun 2017; status: completed.
02
Drugs
treprostinil
03
Conditions
systemic sclerosis (SSc)digital ulcer (DU)
Beyond the preview
Go deeper on NCT03120533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03120533.